Publication: Protocol for the assessment of mTOR activity in mouse primary hepatocytes.
| dc.contributor.author | Plata-Gómez, Ana Belén | |
| dc.contributor.author | Crespo, María | |
| dc.contributor.author | de la Calle Arregui, Celia | |
| dc.contributor.author | de Prado-Rivas, Lucía | |
| dc.contributor.author | Sabio, Guadalupe | |
| dc.contributor.author | Efeyan, Alejo | |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | es_ES |
| dc.contributor.funder | Agencia Estatal de Investigación (España) | es_ES |
| dc.contributor.funder | Unión Europea. Comisión Europea. European Research Council (ERC) | es_ES |
| dc.date.accessioned | 2024-03-11T12:06:07Z | |
| dc.date.available | 2024-03-11T12:06:07Z | |
| dc.date.issued | 2021-12-17 | |
| dc.description.abstract | We present a protocol for measuring the activity of the mechanistic target of rapamycin (mTOR) pathway in ex vivo isolated mouse primary hepatocytes. It can be used as a tool for genetic, pharmacological, metabolomic, and signal transduction procedures. We discuss critical aspects for improving yield, viability, and modulation of the mTOR pathway. This protocol can be adapted to other signaling cascades and is compatible with multiple readouts. For complete details on the use and execution of this protocol, please refer to Ortega-Molina et al. (2021). | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | We thank CNIO Animal Facility for excellent technical support. Research was supported by the RETOS Projects Program of the Spanish Ministry of Science, Innovation and Universities, the Spanish State Research Agency (AEI/10.13039/ 501100011033) co-funded by the European Regional Development Fund (SAF2015-67538-R and PID2019-104012RB-I00), the EU-H2020 Program (ERC-2014-STG638891), an Excellence Network Grant from MICIU/AEI (SAF2016-81975-REDT), a Ramon y Cajal Award from MICIU/AEI (RYC-2013-13546), a SpanishAssociation Against Cancer Research Scientific Foundation laboratory grant (LABAE16001EFEY/AECC), Beca de Investigacio´ n en Oncologı´a Olivia Roddom, a FERO Grant for Research in Oncology (to A.E.), EFSD/Lilly European Diabetes Research Programme, MICIU (PID2019-104399RB-I00), Fundacio´ n AECC PROYE19047SABI, and Comunidad de Madrid IMMUNOTHERCAN-CM B2017/BMD-3733 (to G.S.). A.E. and G.S. are EMBO Young Investigators. A.B.P.-G., M.C., C.d.l.C.A., and L.d.P.-R. are recipients of Ayudas de contratos predoctorales para la formacio´ n de doctores from MICIU/AEI (BES-2017-081381, BES-2017-079711, BES-2015-073776, and PRE-2019-090891). | es_ES |
| dc.format.number | 4 | es_ES |
| dc.format.page | 100918 | es_ES |
| dc.format.volume | 2 | es_ES |
| dc.identifier.citation | STAR Protoc. 2021 Oct 29;2(4):100918. | es_ES |
| dc.identifier.doi | 10.1016/j.xpro.2021.100918 | es_ES |
| dc.identifier.e-issn | 2666-1667 | es_ES |
| dc.identifier.journal | STAR protocols | es_ES |
| dc.identifier.pubmedID | 34755120 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/18915 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Cell Press | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/AEI/10.13039/501100011033 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2015-67538-R | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-104012RB-I00 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2016-81975-REDT | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RYC-2013-13546 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/BES-2017-081381 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/BES-2017-079711 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/BES-2015-073776 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PRE-2019-090891 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-104399RB-I00 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/ERC-2014-STG638891 | es_ES |
| dc.relation.publisherversion | 10.1016/j.xpro.2021.100918 | es_ES |
| dc.repisalud.institucion | CNIC | es_ES |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Papel de las quinasas activadas por el estrés en el desarrollo de enfermedades cardiovasculares, diabetes y cáncer | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | TOR Serine-Threonine Kinases | es_ES |
| dc.subject.mesh | Animals | es_ES |
| dc.subject.mesh | Cell Culture Techniques | es_ES |
| dc.subject.mesh | Cells, Cultured | es_ES |
| dc.subject.mesh | Hepatocytes | es_ES |
| dc.subject.mesh | Liver | es_ES |
| dc.subject.mesh | Mice | es_ES |
| dc.subject.mesh | Signal Transduction | es_ES |
| dc.title | Protocol for the assessment of mTOR activity in mouse primary hepatocytes. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 7de1300f-8563-434d-b693-41b7c8c6fdd1 | |
| relation.isAuthorOfPublication | fa895eb1-39d5-447c-9b8c-314f35de09c9 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7de1300f-8563-434d-b693-41b7c8c6fdd1 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Protocol for the assessment_STAR Protoc_2021.pdf
- Size:
- 3.53 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo


